Botanix Pharmaceuticals (ASX:BOT) FCF Margin %: -183.40% (As of Dec. 2025)


What is Botanix Pharmaceuticals FCF Margin %?

Botanix Pharmaceuticals ASX:BOT -5.00% FCF Margin % is -183.40% as of Dec. 2025. The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Botanix Pharmaceuticals ranks worse than 67.15% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Botanix Pharmaceuticals's Free Cash Flow for the six months ended in Dec. 2025 was A$-30.27 Mil. Botanix Pharmaceuticals's Revenue for the six months ended in Dec. 2025 was A$16.51 Mil. Therefore, Botanix Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2025 was -183.40%.

As of today, Botanix Pharmaceuticals's current FCF Yield % is -151.85%.

The historical rank and industry rank for Botanix Pharmaceuticals's FCF Margin % or its related term are showing as below:

ASX:BOT' s FCF Margin % Range Over the Past 10 Years
Min: -18570.87   Med: -4339.87   Max: -358.11
Current: -358.11

During the past 13 years, the highest FCF Margin % of Botanix Pharmaceuticals was -358.11%. The lowest was -18570.87%. And the median was -4339.87%.

ASX:BOT's FCF Margin % is ranked worse than
67.15% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs ASX:BOT: -358.11

Botanix Pharmaceuticals FCF Margin % Related Terms

Botanix Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Botanix Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Botanix Pharmaceuticals FCF Margin % Chart

Botanix Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -18,570.87 -4,339.87 -1,383.27

Botanix Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,903.70 -3,388.84 -9,079.77 -890.96 -183.40

ASX:BOT vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Botanix Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Botanix Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Botanix Pharmaceuticals's FCF Margin % falls into.


Botanix Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Botanix Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-79.635/5.757
=-1,383.27 %

Botanix Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-30.272/16.506
=-183.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -183.40% mean?
Botanix Pharmaceuticals (ASX:BOT) has a FCF Margin % of -183.40% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Botanix Pharmaceuticals and its competitors. According to the industry distribution chart, Botanix Pharmaceuticals ranks #644 out of 959 companies in the Biotechnology industry, placing it in the top 67.2%.
Is Botanix Pharmaceuticals' FCF Margin % too high?
Botanix Pharmaceuticals' current FCF Margin % is -183.40%. Based on the distribution chart, Botanix Pharmaceuticals ranks #644 out of 959 companies in the Biotechnology industry, which is below the industry midpoint.
How does Botanix Pharmaceuticals' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Botanix Pharmaceuticals ranks #644 out of 959 companies for FCF Margin %. This places Botanix Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Botanix Pharmaceuticals and its competitors. Botanix Pharmaceuticals's current FCF Margin % is -183.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Botanix Pharmaceuticals stock overvalued right now?
Botanix Pharmaceuticals (ASX:BOT) has a current FCF Margin % of -183.40%. The current FCF Margin % is -183.40%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Botanix Pharmaceuticals (ASX:BOT), the current FCF Margin % is -183.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Botanix Pharmaceuticals Business Description

Other Exchanges BXPHF:USA
Address 41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.